Paulo C. Rodrı́guez

This study shows TAp73 regulates lipid metabolism in lung tumor microenvironment to enhance anti-tumor immunity through T-cell activation.

This paper develops synthetic Notch agonists (SNAGs) that activate Notch signaling by pulling on mechanosensitive receptors, demonstrating their effectiveness in targeting multiple biomarkers.

This paper develops computational frameworks to design personalized multi-strike therapies for ovarian cancer that reduce toxicity while enhancing tumor extinction.

This paper analyzes 11,473 tumor samples across 33 cancer types to study gamma delta T cell receptor diversity and its prognostic potential, revealing its significance as a biomarker and therapeutic target.